Assignee: Sigma-Tau Pharmaceuticals, Inc.

Location: Gaithersburg, MD
No. of patents: 4

Number	Title	Issue Date
7333894	Methods for the diagnosis of hemodialysis patients and utilization of such methods to improve the administration of intravenous levocarnitine treatments to hemodialysis patients The disclosed invention pertains to methods for diagnosing clinical conditions that are common in hemodialysis patients and that may be related to abnormal carnitine metabolism resulting from hemodialysis. Further, the present invention pertains to methods for monit...	02/19/2008
7011977	Quantification of carnitine levels in dialysis patients Disclosed herein are methods for diagnosing carnitine deficiency in patients and quantifying that deficiency such that carnitine concentrations can be easily and accurately tracked within a given patient over time. Particular embodiments disclosed herein pertain to ...	03/14/2006
5958886	Carnitine-containing peptides and a method for using the same A carnitine-containing peptide sequence, which is a substrate for a mammalian peptide transport system, which contains at least one carnitine residue with at least one amino acid residue bonded thereto via an amide or ester linkage....	09/28/1999
5686491	Infant formula The present invention provides an infant formula for infants with metabolic disorders in fatty acid catabolism such as medium-chain acyl-CoA dehydrogenase deficiency (MCAD), long-chain acyl-CoA dehydrogenase deficiency (LCAD), short-chain acyl-CoA dehydro...	11/11/1997

PatentStorm